MatthewRubenstein (Matt)

Associate

Minneapolis + 1.612.217.8846

Matt Rubenstein focuses on appellate advocacy, motions practice, and strategic advice throughout all stages of federal and state litigation. Matt has argued before the Seventh Circuit and has drafted briefs in the U.S. Supreme Court, numerous federal courts of appeals, federal district and bankruptcy courts, and state intermediate and high courts.

Matt has experience across a range of substantive areas including patent law, securities litigation, and employment law. He also maintains an active pro bono practice and has represented clients in cases raising issues of habeas, immigration, and veterans law. Before joining Jones Day, Matt served as a law clerk to Justice Ruth Bader Ginsburg of the U.S. Supreme Court, Judge David S. Tatel of the U.S. Court of Appeals for the D.C. Circuit, and Judge James S. Gwin of the U.S. District Court for the Northern District of Ohio. During law school, Matt participated in the Veterans Legal Services Clinic and served as a Coker Fellow, providing mentorship and writing support to 1L students.

Experience

  • Qualcomm wins Federal Circuit appeal on statutory interpretation that "applicant admitted prior art" cannot form the basis of an IPROn behalf of Qualcomm Incorporated, Jones Day won a Federal Circuit appeal on a novel issue of statutory interpretation of the America Invents Act (AIA).
  • U.S. Bank defends patent infringement claims involving gift cards sold in shopping mallsJones Day is defending U.S. Bank National Association in two related patent infringement disputes initially brought by AlexSam, Inc. related to prepaid gift cards sold in Simon shopping malls.
  • Sloan Kettering and Juno Therapeutics win over $1.1 billion after jury verdict and post-trial motions in patent dispute with Kite Pharma/Gilead involving CAR-T therapyOn behalf of patentee Sloan Kettering Institute and exclusive licensee Juno Therapeutics (a subsidiary of Celgene Corporation, a Bristol Myers Squibb company), Jones Day and co-counsel prevailed in a jury trial that spanned eight days and involved 22 witnesses, wherein the jury awarded our clients $752 million in compensation for the infringement of their patents by Kite Pharma, Inc. (a Gilead Sciences, Inc. company) through the making and selling of its infringing CAR-T therapy, YESCARTA®.
  • Legal scholars file amicus brief in Second Circuit in support of sexual assault victim at military academyJones Day filed an amicus brief on behalf of a group of legal scholars to assist the Second Circuit as it considered whether a cadet at the United States Military Academy at West Point could bring claims under the Federal Torts Claims Act for the rape and sexual harassment she endured.